Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 11.07
+0.11 (1.00%)
At close: Feb 26, 2026
Grifols Market Cap
Grifols has a market cap or net worth of €6.69 billion as of February 26, 2026. Its market cap has increased by 14.53% in one year.
Market Cap
6.69B
Enterprise Value
17.93B
Revenue
7.52B
Ranking
n/a
PE Ratio
20.24
Stock Price
€11.07
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 729.00M to 6.69B, an increase of 818.24%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 6.63B | 1.44% |
| Dec 31, 2025 | 6.54B | 15.08% |
| Dec 31, 2024 | 5.68B | -38.46% |
| Dec 29, 2023 | 9.23B | 40.77% |
| Dec 30, 2022 | 6.56B | -32.97% |
| Dec 30, 2021 | 9.78B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laboratorios Farmaceuticos Rovi | 3.99B |
| Almirall | 2.71B |
| Faes Farma | 1.55B |
| Pharma Mar | 1.35B |
| Clínica Baviera | 839.03M |
| Oryzon Genomics | 246.02M |
| Atrys Health | 235.21M |
| Prim, S.A. | 217.80M |